- Home
- CDNA
CDNA
CareDx Inc.
as 11-24-2025 3:39pm EST
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | BRISBANE |
| Market Cap: | 712.2M | IPO Year: | 2014 |
| Target Price: | $26.00 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.96 - $26.37 | Next Earning Date: | 11-04-2025 |
| Revenue: | $357,998,000 | Revenue Growth: | 14.46% |
| Revenue Growth (this year): | 12.73% | Revenue Growth (next year): | 11.90% |
Stock Insider Trading Activity of CareDx Inc. (CDNA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Novack Jeffrey Adam | CDNA | Secretary and General Counsel | Nov 7 '25 | Sell | $15.52 | 2,688 | $41,722.87 | 105,218 |
Latest CareDx Inc. News
CDNA Breaking Stock News: Dive into CDNA Ticker-Specific Updates for Smart Investing
Business Wire
2 months ago
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
MT Newswires
6 months ago
CareDx Launches New $50 Million Share Buyback Plan
Business Wire
6 months ago
CareDx Announces Repurchase of 5% of Outstanding Shares
MT Newswires
6 months ago
Caredx Insider Sold Shares Worth $523,413, According to a Recent SEC Filing
MT Newswires
6 months ago
Caredx Insider Sold Shares Worth $465,022, According to a Recent SEC Filing
Business Wire
6 months ago
CareDx to Participate in Upcoming Investor Conferences
Simply Wall St.
7 months ago
Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position
Simply Wall St.
7 months ago
An Intrinsic Calculation For CareDx, Inc (NASDAQ:CDNA) Suggests It's 28% Undervalued
Compare CDNA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CDNA CareDx Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.